Cost-Effectiveness of the Adjuvant Recombinant Zoster Vaccine in Japanese Adults Aged 65 Years and Older

INTRODUCTION: The incidence of herpes zoster (HZ) rises steeply after the age of 50 years and the number of HZ cases and complications such as postherpetic neuralgia (PHN) is predicted to increase because of the ageing population. The objective of this study was to estimate the cost-effectiveness of...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Dermatol Ther (Heidelb)
Huvudupphovsmän: Shiragami, Makoto, Mizukami, Akiko, Kaise, Toshihiko, Curran, Desmond, Van Oorschot, Desiree, Bracke, Benjamin, Watanabe, Daisuke
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Healthcare 2019
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522608/
https://ncbi.nlm.nih.gov/pubmed/30929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-019-0291-4
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk